ArticleOne health (Amsterdam, Netherlands)2017
Dromedary camels in northern Mali have high seropositivity to MERS-CoV.
Article in One health (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- Serological and virological evidence of MERS-CoV infection among dromedary camels in Africa: a systematic review and Meta-analysis.Veterinary research communications · 2026Pooled it
- A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.Epidemics · 2019Pooled it
- Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review.Epidemiology and infection · 2019Pooled it
- A Newly Established ELISA for the Surveillance of Rift Valley Fever in Dromedary Camels and Their Owners, Kenya 2018.Viruses · 2026Article
- Article
- An overview of literature on COVID-19, MERS and SARS: Using text mining and latent Dirichlet allocation.Journal of information science · 2022Article
- Systematic review and meta-analysis of the prevalence of coronavirus: One health approach for a global strategy.One health (Amsterdam, Netherlands) · 2022Review
- Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali.The Journal of infectious diseases · 2021Article
- Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014-2018.Emerging infectious diseases · 2021Article
- Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection.Pharmaceuticals (Basel, Switzerland) · 2021Article
- The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.Chemical biology & drug design · 2020Review
- Article
- Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.Epidemiology and infection · 2020Article
- Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.Open veterinary journal · 2020Review
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.Microorganisms · 2020Review
- Challenge infection model for MERS-CoV based on naturally infected camels.Virology journal · 2020Article
- A database of geopositioned Middle East Respiratory Syndrome Coronavirus occurrences.Scientific data · 2019Article
- Some One Health based control strategies for the Middle East respiratory syndrome coronavirus.One health (Amsterdam, Netherlands) · 2019Review
- Detection of MERS-CoV antigen on formalin-fixed paraffin-embedded nasal tissue of alpacas by immunohistochemistry using human monoclonal antibodies directed against different epitopes of the spike protein.Veterinary immunology and immunopathology · 2019Article
- Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 3 institutions in 2 countries.
Funding
Abstract
A high percentage (up to 90%) of dromedary camels in the Middle East as well as eastern and central Africa have antibodies to Middle East respiratory syndrome coronavirus (MERS-CoV). Here we report comparably high positivity of MERS-CoV antibodies in dromedary camels from northern Mali. This extends the range of MERS-CoV further west in Africa than reported to date and cautions that MERS-CoV should be considered in cases of severe respiratory disease in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.